Late-stage data buoys Merck's Keytruda as second-line hepatocellular carcinoma treatment
19 Januar 2022 - 12:05AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024